z-logo
open-access-imgOpen Access
Quality Improvement Methodology Optimizes Infliximab Levels in Pediatric Patients with Inflammatory Bowel Disease
Author(s) -
Jennifer Hellmann,
Renee K Etter,
Lee A. Denson,
Phillip Minar,
Denise M. Hill,
Dana M. H. Dykes,
Michael J. Rosen
Publication year - 2021
Publication title -
pediatric quality and safety
Language(s) - English
Resource type - Journals
ISSN - 2472-0054
DOI - 10.1097/pq9.0000000000000400
Subject(s) - infliximab , medicine , guideline , inflammatory bowel disease , quality management , drug , disease , physical therapy , pharmacology , management system , management , pathology , economics
Supplemental Digital Content is available in the text.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here